Arcus Biosciences, Inc.
SOLID FORMS OF A CD73 INHIBITOR AND THE USE THEREOF

Last updated:

Abstract:

Solid forms of Compound I, which modulates the conversion of AMP to adenosine by 5'-nucleotidase, ecto, and compositions containing the compound and methods for preparing the solid forms, are described herein. The use of such solid form of Compound I and compositions for the treatment and/or prevention of a diverse array of diseases, disorders and conditions, including cancer- and immune-related disorders, that are mediated by 5'-nucleotidase, ecto is also provided.

Status:
Application
Type:

Utility

Filling date:

12 Dec 2019

Issue date:

3 Mar 2022